Journal article
Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users
Abstract
BACKGROUND: For patients on warfarin therapy an international normalized ratio (INR) recall interval not exceeding 4 weeks has traditionally been recommended. For patients whose INR values are nearly always therapeutic, less frequent INR monitoring may be feasible.
OBJECTIVE: To identify patients with stable INRs (INR values exclusively within the INR range) and comparator patients (at least one INR outside the INR range), compare occurrences …
Authors
WITT DM; DELATE T; CLARK NP; MARTELL C; TRAN T; CROWTHER MA; GARCIA DA; AGENO W; HYLEK EM; CONSORTIUM OBOTW
Journal
Journal of Thrombosis and Haemostasis, Vol. 8, No. 4, pp. 744–749
Publisher
Elsevier
Publication Date
April 2010
DOI
10.1111/j.1538-7836.2010.03756.x
ISSN
1538-7933
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
Age FactorsAgedAged, 80 and overAnticoagulantsBlood CoagulationChi-Square DistributionDrug MonitoringFemaleHemorrhageHumansInternational Normalized RatioLogistic ModelsLongitudinal StudiesMaleMiddle AgedPredictive Value of TestsRecurrenceRetrospective StudiesRisk AssessmentRisk FactorsSex FactorsThromboembolismTime FactorsWarfarin